Aptose Biosciences
APTO
#10454
Rank
NZ$7.55 M
Marketcap
NZ$2.96
Share price
0.00%
Change (1 day)
802.39%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -NZ$34.7 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$43.67 Million, an increase over its 2023 earnings that were of -NZ$90.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$34.7 Million-20.55%
2024 -NZ$43.67 Million-51.82%
2023 -NZ$90.64 Million22.9%
2022 -NZ$73.75 Million-34.91%
2021 -NZ$0.12 Billion17.36%
2020 -NZ$96.54 Million107.65%
2019 -NZ$46.5 Million-7.73%
2018 -NZ$50.39 Million160.68%
2017 -NZ$19.33 Million-20.27%
2016 -NZ$24.25 Million28.71%
2015 -NZ$18.84 Million
2013 -NZ$10.68 Million
2010 -NZ$9.1 Million-8.31%
2009 -NZ$9.92 Million
2006 -NZ$18.39 Million-156.93%
2005 NZ$32.29 M-185.16%
2004 -NZ$37.93 Million458.58%
2003 -NZ$6.79 Million-63.66%
2002 -NZ$18.69 Million-8.04%
2001 -NZ$20.32 Million16.73%
2000 -NZ$17.41 Million294.99%
1999 -NZ$4.41 Million-6.51%
1998 -NZ$4.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Advaxis
ADXS
-NZ$58.9 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-NZ$0.12 Billion 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-NZ$0.11 Billion 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA